| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.2M | +587.1% |
| SG&A Expense | $51.2M | — |
| Operating Income | -$52.5M | -8229.4% |
| Interest Expense | $575K | -34.4% |
| Income Tax | $0 | — |
| Net Income | $10.2M | +107.2% |
| EPS (Basic) | $0.02 | +104.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.6M | — |
| Current Assets | $6.7M | +5498.0% |
| Total Assets | $6.7M | +4212.3% |
| Current Liabilities | $2K | -100.0% |
| Total Liabilities | $2K | -100.0% |
| Stockholders' Equity | $3.2M | +102.1% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.1M | -222.0% |
| Financing Cash Flow | $8.7M | +1235.4% |